Viruses 2012, 4(8), 1279-1288; doi:10.3390/v4081279
Communication

A Limited Structural Modification Results in a Significantly More Efficacious Diazachrysene-Based Filovirus Inhibitor

1 University of Belgrade, Studentski trg 16, P.O. Box 51, Belgrade 11158, Serbia 2 Institute of Chemistry, Technology, and Metallurgy, University of Belgrade, Belgrade 11000, Serbia 3 United States Army Medical Research Institute of Institute of Infectious Diseases, Fort Detrick, 1425 Porter Street, Frederick, MD 21702, USA 4 SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, P.O. Box B, Frederick, MD 21702, USA
* Authors to whom correspondence should be addressed.
Received: 3 July 2012; in revised form: 7 August 2012 / Accepted: 8 August 2012 / Published: 15 August 2012
(This article belongs to the Special Issue Advances in Filovirus Research 2012)
PDF Full-text Download PDF Full-Text [481 KB, uploaded 15 August 2012 16:00 CEST]
Abstract: Ebola (EBOV) and Marburg (MARV) filoviruses are highly infectious pathogens causing deadly hemorrhagic fever in humans and non-human primates. Promising vaccine candidates providing immunity against filoviruses have been reported. However, the sporadic nature and swift progression of filovirus disease underlines the need for the development of small molecule therapeutics providing immediate antiviral effects. Herein we describe a brief structural exploration of two previously reported diazachrysene (DAAC)-based EBOV inhibitors. Specifically, three analogs were prepared to examine how slight substituent modifications would affect inhibitory efficacy and inhibitor-mediated toxicity during not only EBOV, but also MARV cellular infection. Of the three analogs, one was highly efficacious, providing IC50 values of 0.696 µM ± 0.13 µM and 2.76 µM ± 0.21 µM against EBOV and MARV infection, respectively, with little or no associated cellular toxicity. Overall, the structure-activity and structure-toxicity results from this study provide a framework for the future development of DAAC-based filovirus inhibitors that will be both active and non-toxic in vivo.
Keywords: filovirus; Ebola virus; Marburg virus; antiviral; diazachrysene; inhibitory efficacy; toxicity; small molecule

Supplementary Files

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Selaković, Ž.; Opsenica, D.; Eaton, B.; Retterer, C.; Bavari, S.; Burnett, J.C.; Šolaja, B.A.; Panchal, R.G. A Limited Structural Modification Results in a Significantly More Efficacious Diazachrysene-Based Filovirus Inhibitor. Viruses 2012, 4, 1279-1288.

AMA Style

Selaković Ž, Opsenica D, Eaton B, Retterer C, Bavari S, Burnett JC, Šolaja BA, Panchal RG. A Limited Structural Modification Results in a Significantly More Efficacious Diazachrysene-Based Filovirus Inhibitor. Viruses. 2012; 4(8):1279-1288.

Chicago/Turabian Style

Selaković, Života; Opsenica, Dejan; Eaton, Brett; Retterer, Cary; Bavari, Sina; Burnett, James C.; Šolaja, Bogdan A.; Panchal, Rekha G. 2012. "A Limited Structural Modification Results in a Significantly More Efficacious Diazachrysene-Based Filovirus Inhibitor." Viruses 4, no. 8: 1279-1288.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert